Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 213.50
Bid: 212.50
Ask: 213.50
Change: -2.00 (-0.93%)
Spread: 1.00 (0.471%)
Open: 217.00
High: 218.50
Low: 211.50
Prev. Close: 215.50
TCAP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re acquisition

2 Feb 2016 07:00

RNS Number : 7435N
Tullett Prebon PLC
02 February 2016
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

FOR IMMEDIATE RELEASE

2 February 2016

 

 

Tullett Prebon plc

 

 

Update on the proposed acquisition of ICAP's global hybrid voice broking and information business

 

 

Further to the announcement regarding the proposed acquisition by Tullett Prebon of ICAP's global hybrid voice broking and information business released on 11 November 2015 (the "Announcement"), Tullett Prebon is updating shareholders in relation to the clearance sought from the United States Department of Justice (the "DOJ") in connection with the Transaction. Terms defined in the Announcement have the same meanings in this announcement.

 

Tullett Prebon has received a request for additional information and documentary material from the DOJ in connection with the Transaction. This form of request from the DOJ, often referred to as a "Second Request", is part of the regulatory process under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). Tullett Prebon understands that the DOJ's review is focused on the proposed post completion shareholding and governance arrangements between Tullett Prebon and ICAP Newco.

 

The effect of the Second Request is to extend the waiting period imposed by the HSR Act until 30 days after Tullett Prebon and ICAP have substantially complied with the Second Request, unless that period is extended voluntarily by the companies or terminated earlier. Tullett Prebon intends to respond to the request from the DOJ as quickly as practicable and to continue to work cooperatively with the DOJ in connection with its review of the Transaction.

 

Completion of the Transaction remains subject to the approval of Tullett Prebon shareholders, the approval of ICAP shareholders, clearance from the Competition and Markets Authority ("CMA"), expiration or termination of all applicable waiting periods under the HSR Act, clearance from certain other antitrust authorities, approval by various regulatory bodies including the FCA, and satisfaction of other customary closing conditions noted in the Announcement.

 

Tullett Prebon continues to anticipate that the Transaction will close in 2016.

 

 

Enquiries

Stephen Breslin

Group Head of Communications, Tullett Prebon plc

Direct: +44 (0) 20 7200 7750

Email: sbreslin@tullettprebon.com

Craig Breheny

Brunswick Group LLP

Direct: +44 (0) 20 7396 7429

Email: cbreheny@brunswickgroup.com

 

 

 

Important notice

This announcement has been issued by and is the sole responsibility of Tullett Prebon.

 

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities pursuant to this announcement or otherwise. The distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

 

This announcement does not constitute an offer of securities for sale in the United States or an offer to acquire or exchange securities in the United States. No offer to acquire securities or to exchange securities for other securities has been made, or will be made, and no offer of securities has been made, or will be made, directly or indirectly, in or into, or by use of the mails, any means or instrumentality of interstate or foreign commerce or any facilities of a national securities exchange of, the United States of America or any other country in which such offer may not be made other than (i) in accordance with the requirements under the US Securities Exchange Act of 1934, as amended, a registration statement under the US Securities Act of 1933, as amended, or the securities laws of such other country, as the case may be, or (ii) pursuant to an available exemption therefrom. No securities are intended to be registered under the US Securities Act of 1933, as amended.

 

This announcement has been prepared for the purposes of complying with the applicable law and regulation of the United Kingdom (including the Listing Rules and the Disclosure and Transparency Rules) and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom.

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

 

This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward looking statements include all matters that are not historical facts and involve predictions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect Tullett Prebon's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to Tullett Prebon's results of operations, financial position, liquidity, prospects, growth or strategies and the industry in which Tullett Prebon operates. Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance. Save as required by law or regulation, Tullett Prebon disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements in this announcement that may occur due to any change in its expectations or to reflect events or circumstances after the date of this announcement.

 

Except as explicitly stated, neither the content of Tullett Prebon's website, nor any website accessible by hyperlinks on Tullett Prebon's website is incorporated in, or forms part of, this announcement.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRAKBDQABKKOBK
Date   Source Headline
23rd Nov 201611:29 amRNSHolding(s) in Company
15th Nov 201612:09 pmRNSStatement re transaction with ICAP
4th Nov 20167:00 amRNSTrading Statement
1st Nov 201612:52 pmRNSDirector Declaration
3rd Oct 20162:34 pmRNSTP ICAP Global Executive Committee
3rd Oct 20162:29 pmRNSTullett Prebon Management Changes
3rd Oct 20169:55 amRNSTotal Voting Rights
27th Sep 20162:15 pmRNSAdditional Listing
26th Sep 20167:03 amRNSStatement re transaction with ICAP
12th Sep 20163:49 pmRNSPublication of Supplementary Prospectus
8th Sep 201612:20 pmRNSStatement on transaction with Tullett Prebon
8th Sep 201612:15 pmRNSStatement re transaction with ICAP
24th Aug 20162:15 pmRNSHolding(s) in Company
3rd Aug 20162:15 pmRNSDirector/PDMR Shareholding
2nd Aug 20169:08 amRNSNew Technology Centre, Belfast Northern Ireland
2nd Aug 20167:00 amRNSHalf-year Report
22nd Jul 20161:15 pmRNSStatement re transaction with ICAP
29th Jun 20166:00 pmRNSNotification of Interim Results
21st Jun 20166:25 pmRNSStatement re transaction with ICAP
20th Jun 201610:21 amRNSHolding(s) in Company
7th Jun 20167:09 amRNSStatement re. CMA announcement
6th Jun 20164:18 pmRNSHolding(s) in Company
16th May 201612:08 pmRNSPublication of Supplementary Prospectus
16th May 20167:13 amRNSIGBB FY 2016 results
13th May 201612:16 pmRNSDirectorate Change
13th May 201610:17 amRNSResult of AGM
12th May 20167:00 amRNSTrading Statement
6th May 20167:00 amRNSDirectorate Change
5th May 20164:41 pmRNSDirector/PDMR Shareholding
4th May 201612:51 pmRNSHolding(s) in Company
22nd Apr 20165:18 pmRNSDirector/PDMR Shareholding
19th Apr 20165:27 pmRNSDirector/PDMR Shareholding
5th Apr 20162:49 pmRNSPublication of Supplementary Prospectus
4th Apr 20164:48 pmRNSAnnual Financial Report
24th Mar 20162:16 pmRNSEGM Statement
1st Mar 201611:37 amRNSPublication of Prospectus
1st Mar 20167:00 amRNSFinal Results
1st Mar 20167:00 amRNSStatement re acquisition
5th Feb 20168:00 amRNSAdoption of Financial Reporting Standard (FRS)101
2nd Feb 20167:00 amRNSStatement re acquisition
29th Jan 20167:00 amRNSBusiness Update
27th Jan 20165:35 pmRNSNotification of Preliminary Results
26th Jan 20164:01 pmRNSHolding(s) in Company
18th Jan 20164:10 pmRNSHolding(s) in Company
4th Jan 20165:01 pmRNSTotal Voting Rights
22nd Dec 20155:53 pmRNSDirector/PDMR Shareholding
30th Nov 20155:19 pmRNSHolding(s) in Company
13th Nov 20153:39 pmRNSHolding(s) in Company
12th Nov 20154:11 pmRNSHolding(s) in Company
11th Nov 20157:16 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.